Product logins

Find logins to all Clarivate products below.


Peripheral Vascular Devices | Medtech 360 | Market Insights | Asia Pacific | 2021

The Asia Pacific market for PV devices will grow modestly through 2029, fueled by the growing PAD population and the adoption of premium devices like DCBs, DES, and powered thrombectomy devices. However, lack of reimbursement, cost constraints, and the impact of COVID-19 pandemic will limit market growth to some extent.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for PV devices in the Asia Pacific region across a 10-year period.

Related Medtech Insights Reports

Report
Peripheral Vascular Devices – Market Insights – United States
The US PV device market will be primarily driven by product innovation, novel technologies, and adoption of premium solutions. However, barriers such as the push for cost-effective PV interventions…
Report
Peripheral Vascular Devices – Market Insights – Europe
The European PV device market will be mainly driven by the increasing availability of premium-priced products and emerging products which, supported by clinical data, will increase the penetration…
Report
Urological Devices – Market Insights – Asia Pacific
Driven by rising kidney stone prevalence and an aging population, the Asia Pacific urological device market will grow at a modest rate through 2034. Other contributing factors for growth include an…
Report
Interventional Oncology Devices – Market Insights – Asia Pacific
The Asia Pacific interventional oncology device market will see strong growth through 2034, driven by updated clinical guidelines, broader access to minimally invasive cancer treatments, and…
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Asia Pacific
The Asia Pacific EP mapping and ablation device market will experience strong growth through 2034, driven by rising procedure volumes, new product launches, increasing prevalence of cardiac…